Evidence map›Paper›PMID 19841951›Full record

ArticleJournal of molecular modeling2010

Docking and 3D-QSAR studies of acetohydroxy acid synthase inhibitor sulfonylurea derivatives.

Kunal Roy, Somnath Paul

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kunal RoyDrug Theoretics and Cheminformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India. kunalroy_in@yahoo.com
Somnath Paul

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Docking and three dimensional quantitative-structure activity relationship (3D-QSAR) studies were performed on acetohydroxy acid synthase (AHAS) inhibitor sulfonylurea analogues with potential herbicidal activity. The 3D-QSAR studies were carried out using shape, spatial and electronic descriptors along with a few structural parameters. Genetic function approximation (GFA) was used as the chemometric tool for this analysis. The whole data set (n = 45) was divided into a training set (75% of the data set) and a test set (remaining 25%) on the basis of the K-means clustering technique on a standardised topological, physicochemical and structural descriptor matrix. Models developed from the training set were used to predict the activity of the test set compounds. All models were validated internally, externally and using the Y-randomisation technique. Docking studies suggested that the molecules bind within a pocket of the enzyme formed by some important amino acid residues (Met351, Asp375, Arg377, Gly509, Met570 and Val571). In QSAR studies, molecular shape analysis showed that bulky substitution at the R(1) position may enhance AHAS inhibitory activity. Charged surface area descriptors suggested that negative charge distributed over a large surface area may enhance this activity. The hydrogen bond acceptor parameter supported the charged surface area descriptors and suggested that, for better activity, the number of electronegative atoms present in the molecule should be high. The spatial descriptors show that, for better activity, the molecules should possess a bulky substituent and a small substitution at the R(2) and R(3) positions, respectively.

Indexed as

Quantitative Structure-Activity RelationshipAcetolactate SynthaseBiophysical PhenomenaEnzyme InhibitorsResearchSulfonylurea CompoundsAcetolactate SynthaseEnzyme InhibitorsSulfonylurea Compounds

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.